{"id":447999,"title":"Notice: Prescription Drug List (PDL): Multiple additions [2019-03-28] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T15:47:49.798000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-2019-03-28.html?wbdisable=false","snippet":"Notice: Prescription Drug List (PDL): Multiple Additions Date: March 28, 2019 Our file number: 19-106933-519 The purpose of this Notice of Amendment is to notify about the additions of axicabtagene ciloleucel, cenegermin, dacomitinib. enasidenib, and lorlatinib to the…","rawSnapshotUrl":"/api/snapshots/raw/447999","browseUrl":"https://replay.healtharchive.ca/job-6/20260103154749/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notice-prescription-drug-list-2019-03-28.html?wbdisable=false#ha_snapshot=447999","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}